The 4S study and its pharmacoeconomic implications.
Reckless
J P
JP
School of Postgraduate Medicine, University of Bath, England.
D000924:Anticholesteremic Agents / Q000191:economics* / Q000627:therapeutic use; D003327:Coronary Disease / Q000191:economics* / Q000517:prevention & control; D003362:Cost-Benefit Analysis; D006801:Humans; D008148:Lovastatin / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D012537:Scandinavian and Nordic Countries; D019821:Simvastatin